Gyssens I C, Geerligs I E, Dony J M, van der Vliet J A, van Kampen A, van den Broek P J, Hekster Y A, van der Meer J W
Department of General Internal Medicine, University Hospital Nijmegen, The Netherlands.
J Antimicrob Chemother. 1996 Dec;38(6):1001-12. doi: 10.1093/jac/38.6.1001.
Following a one-month prospective study of antimicrobial drug use in surgical departments, new guidelines were implemented. The review was repeated after two years. In both study periods, one third of patients were prescribed antimicrobial drugs. Prophylactic antibiotic consumption decreased from 0.75 to 0.53 defined daily doses/operation. Compliance with guidelines improved from 32% to 79%. Duration of prophylaxis > 24 h decreased from 21% to 8%. Single dose prophylaxis increased from 34% to 80%. Quality of the prophylactic courses improved, as evaluated by experts using established criteria. For prophylaxis, cost savings amounted to 57%. Better quality of therapeutic courses was associated with a cost increase of 15%. Indicators of satisfactory outcome with the new policy were a stable median length of stay (5.5 days in the first review and 5.0 days after intervention) and a reduction in the number of nosocomial infections treated with antimicrobial drugs/100 bed days (1.0 before intervention vs 0.77 after intervention).
在对外科科室抗菌药物使用情况进行了为期一个月的前瞻性研究之后,新的指导方针得以实施。两年后重复了该项审查。在两个研究期间,三分之一的患者都被开具了抗菌药物。预防性抗生素的消耗量从0.75限定日剂量/手术降至0.53限定日剂量/手术。对指导方针的依从性从32%提高到了79%。预防性用药持续时间>24小时的情况从21%降至8%。单次剂量预防性用药从34%增至80%。按照专家使用既定标准进行的评估,预防性疗程的质量有所提高。在预防性用药方面,成本节约达57%。治疗疗程质量的提高与成本增加15%相关。新政策下令人满意的结果指标包括住院时间中位数稳定(首次审查时为5.5天,干预后为5.0天)以及每100个床日接受抗菌药物治疗的医院感染数量减少(干预前为1.0,干预后为0.77)。